Histopathologic assessment of pancreatic cancer: Does one size fit all?

Journal of Surgical Oncology

Volumn 107, Issue 1, 2013, Pages 67-77

  Reid, Michelle D ^a,c   Bagci, Pelin ^b   Adsay, N Volkan ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

cancer; histopathology; pancreatic

Indexed keywords

CHROMOGRANIN A; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; KI 67 ANTIGEN; PROTEIN P16; PROTEIN P53; SMAD4 PROTEIN; SYNAPTOPHYSIN;

ACINAR CELL CARCINOMA; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CLASSIFICATION; CANCER PATIENT; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL LINEAGE; COLLOID CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOCARCINOMA; CYSTADENOMA; EPITHELIUM CELL; GASTROINTESTINAL CARCINOMA; GENE MUTATION; GIANT CELL CARCINOMA; HISTOGENESIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INSULINOMA; INTRADUCTAL CARCINOMA; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; LYMPHOMA; MEDULLARY CARCINOMA; MELANOMA; METASTASIS; MICROADENOMA; MUCINOUS CYSTIC NEOPLASM; ONCOGENE K RAS; OSTEOCLASTIC GIANT CELL CARCINOMA; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PANCREAS CANCER; PANCREAS ISLET; PANCREATIC NEUROENDOCRINE TUMOR; PANCREATICODUODENECTOMY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMA; SOLID PSEUDOPAPILLARY TUMOR; SURVIVAL RATE; TUMOR GROWTH; UNDIFFERENTIATED CARCINOMA;

CARCINOMA IN SITU; CARCINOMA, ACINAR CELL; CARCINOMA, PANCREATIC DUCTAL; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS;

EID: 84871275135     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23194     Document Type: Article

References (79)

1. Klimstra D, Adsay N,: Benign and malignant tumors of the pancreas. In:, Odze R, Goldblum J, Crawford J, editors. Surgical pathology of the GI tract, liver, biliary tract and pancreas. Philadelphia, PA: Saunders; 2003. pp. 699-731.
2. Klimstra DS, Adsay NV,: Benign and malignant tumors of the pancreas. In:, Odze R, Goldblum J, Crawford JM, editors. Surgical pathology of the GI tract, liver, biliary tract and pancreas. Philadelphia, PA: Saunders; 2003. pp. 699-731.
3. Lowe MC, Coban I, Adsay NV, et al.: Important prognostic factors in adenocarcinoma of the ampulla of Vater. Am Surg 2009; 75: 754-760, discussion 761.
4. Adsay V, Logani S, Sarkar F, et al.: Foamy gland pattern of pancreatic ductal adenocarcinoma: A deceptively benign-appearing variant. Am J Surg Pathol 2000; 24: 493-504.
5. Dursun N, Feng J, Basturk O, et al.: Vacuolated cell pattern of pancreatobiliary adenocarcinoma: A clinicopathological analysis of 24 cases of a poorly recognized distinctive morphologic variant important in the differential diagnosis. Virchows Arch 2010; 457: 643-649.
6. Bagci P, Andea AA, Basturk O, et al.: Large duct type invasive adenocarcinoma of the pancreas with microcystic and papillary patterns: A potential microscopic mimic of non-invasive ductal neoplasia. Mod Pathol 2012; 25: 439-448.
7. Kosmahl M, Pauser U, Anlauf M, et al.: Pancreatic ductal adenocarcinomas with cystic features: Neither rare nor uniform. Mod Pathol 2005; 18: 1157-1164.
8. Adsay NV, Basturk O, Altinel D, et al.: The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: Comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol 2009; 22: 107-112.
9. Luttges J, Vogel I, Menke M, et al.: The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch 1998; 433: 237-242.
10. Bandyopadhyay S, Basturk O, Coban I, et al.: Isolated solitary ducts (naked ducts) in adipose tissue: A specific but underappreciated finding of pancreatic adenocarcinoma and one of the potential reasons of understaging and high recurrence rate. Am J Surg Pathol 2009; 33: 425-429.
11. Vyas P, Andea A, Othman M, et al.: A modified approach to dissection of pancreatoduodenectomy (PD) specimens for a more accurate but practical assessment of the clinically relevant pathologic parameters (abstract). Mod Pathol 2003; 16: 288A.
12. Oliva I, Bandyopadhyay S, Coban I, et al.: Peripancreatic soft tissue involvement by pancreatic ductal adenocarcinomas: Incidence, patterns and significance (abstract). Mod Pathol 2009; 22: 318A.
13. Adsay NV, Klimstra DS,: Pathology and classification of pancreatic and ampullary tumors. In:, Blumgart L, editor. Surgery of the liver, biliary tract, and pancreas. Philadelphia, PA: Saunders; 2006. pp. 829-847.
14. DiGiuseppe JA, Hruban RH, Offerhaus GJ, et al.: Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 1994; 144: 889-895.
15. Moskaluk CA, Hruban RH, Kern SE,: p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res 1997; 57: 2140-2143.
16. Hruban RH, Iacobuzio-Donahue C, Wilentz RE, et al.: Molecular pathology of pancreatic cancer. Cancer J 2001; 7: 251-258.
17. Barton CM, Staddon SL, Hughes CM, et al.: Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 1991; 64: 1076-1082.
18. DiGiuseppe JA, Hruban RH, Goodman SN, et al.: Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994; 101: 684-688.
19. Schutte M,: DPC4/SMAD4 gene alterations in human cancer, and their functional implications. Ann Oncol 1999; 10: 56-59.
20. Sommers SC, Murphy SA, Warren S,: Pancreatic duct hyperplasia and cancer. Gastroenterology 1954; 27: 629-640.
21. Hruban RH, Adsay NV, Albores-Saavedra J, et al.: Pancreatic intraepithelial neoplasia: A new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001; 25: 579-586.
22. Hruban RH, Maitra A, Kern SE, et al.: Precursors to pancreatic cancer. Gastroenterol Clin North Am 2007; 36: 831-849, vi.
23. Kozuka S, Sassa R, Taki T, et al.: Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979; 43: 1418-1428.
24. Andea A, Sarkar F, Adsay VN,: Clinicopathological correlates of pancreatic intraepithelial neoplasia: A comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003; 16: 996-1006.
25. Klimstra DS, Adsay NV,: Tumors of the pancreas and ampulla of vater. In:, Odze RD, Goldblum JR, editor. Surgical pathology of the GI tract, liver, biliary tract and pancreas. Philadelphia, PA: Saunders; 2008; 909-960.
26. Adsay NV, Basturk O, Cheng JD, et al.: Ductal neoplasia of the pancreas: Nosologic, clinicopathologic, and biologic aspects. Semin Radiat Oncol 2005; 15: 254-264.
27. Hoorens A, Prenzel K, Lemoine NR, et al.: Undifferentiated carcinoma of the pancreas: Analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin. J Pathol 1998; 185: 53-60.
28. Westra WH, Sturm P, Drillenburg P, et al.: K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: Genetic evidence to support origin from the duct epithelium. Am J Surg Pathol 1998; 22: 1247-1254.
29. Nojima T, Nakamura F, Ishikura M, et al.: Pleomorphic carcinoma of the pancreas with osteoclast-like giant cells. Int J Pancreatol 1993; 14: 275-281.
30. Hruban RHPM, Klimstra DS,: Tumors of the pancreas. Washington, DC: ARP Press; 2007.
31. Lukas Z, Dvorak K, Kroupova I, et al.: Immunohistochemical and genetic analysis of osteoclastic giant cell tumor of the pancreas. Pancreas 2006; 32: 325-329.
32. Molberg KH, Heffess C, Delgado R, et al.: Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region. Cancer 1998; 82: 1279-1287.
33. Kardon DE, Thompson LD, Przygodzki RM, et al.: Adenosquamous carcinoma of the pancreas: A clinicopathologic series of 25 cases. Mod Pathol 2001; 14: 443-451.
34. Adsay NV, Pierson C, Sarkar F, et al.: Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001; 25: 26-42.
35. Wilentz RE, Goggins M, Redston M, et al.: Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol 2000; 156: 1641-1651.
36. Nakata B, Yashiro M, Nishioka N, et al.: Very low incidence of microsatellite instability in intraductal papillary-mucinous neoplasm of the pancreas. Int J Cancer 2002; 102: 655-659.
37. Wilentz RE, Albores-Saavedra J, Hruban RH,: Mucinous cystic neoplasms of the pancreas. Semin Diagn Pathol 2000; 17: 31-42.
38. Thompson LD, Becker RC, Przygodzki RM, et al.: Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: A clinicopathologic study of 130 cases. Am J Surg Pathol 1999; 23: 1-16.
39. Zamboni G, Fukushima N, Hruban R, et al.: Mucinous cystic neoplasms of the pancreas. In:, F Bosman, F Carneiro, R Hruban, N Theise, editors. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010. pp. 300-303.
40. Lewandrowski K, Lee J, Southern J, et al.: Cyst fluid analysis in the differential diagnosis of pancreatic cysts: A new approach to the preoperative assessment of pancreatic cystic lesions. AJR Am J Roentgenol 1995; 164: 815-819.
41. Zamboni G, Scarpa A, Bogina G, et al.: Mucinous cystic tumors of the pancreas: Clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999; 23: 410-422.
42. Sarr MG, Carpenter HA, Prabhakar LP, et al.: Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: Can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 2000; 231: 205-212.
43. Jang K, Dursun N, Basturk O, et al.: Invasive carcinomas arising from pancreatic mucinous cystic neoplasms (MCNS) with ovarian stroma: A clinicopathologic analysis of 25 cases with invasive carcinoma identified in 131 MCNS (abstract). Mod Pathol 2011; 24: 363A.
44. Basturk O, Coban I, Adsay NV,: Pancreatic cysts: Pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med 2009; 133: 423-438.
45. Yamaguchi H, Shimizu M, Ban S, et al.: Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2009; 33: 1164-1172.
46. Adsay N, Fukushima N, Furukawa T, et al.: Intraductal neoplasms of the pancreas. In:, Bosman F, Carneiro F, Hruban R, Theise N, editors. WHO Classification of Tumors of the Digestive System. Lyon, France: IARC Press; 2010. pp. 304-313.
47. Yamada M, Kozuka S, Yamao K, et al.: Mucin-producing tumor of the pancreas. Cancer 1991; 68: 159-168.
48. Yamaguchi K, Tanaka M,: Mucin-hypersecreting tumor of the pancreas with mucin extrusion through an enlarged papilla. Am J Gastroenterol 1991; 86: 835-839.
49. Adsay NV, Conlon KC, Zee SY, et al.: Intraductal papillary-mucinous neoplasms of the pancreas: An analysis of in situ and invasive carcinomas in 28 patients. Cancer 2002; 94: 62-77.
50. Sugiyama M, Izumisato Y, Abe N, et al.: Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 2003; 90: 1244-1249.
51. Kobari M, Egawa S, Shibuya K, et al.: Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: Differences in clinical characteristics and surgical management. Arch Surg 1999; 134: 1131-1136.
52. Salvia R, Fernandez-del Castillo C, Bassi C, et al.: Main-duct intraductal papillary mucinous neoplasms of the pancreas: Clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004; 239: 678-685, discussion 685-677.
53. Galanis C, Zamani A, Cameron JL, et al.: Resected serous cystic neoplasms of the pancreas: A review of 158 patients with recommendations for treatment. J Gastrointest Surg 2007; 11: 820-826.
54. King JC, Ng TT, White SC, et al.: Pancreatic serous cystadenocarcinoma: A case report and review of the literature. J Gastrointest Surg 2009; 13: 1864-1868.
55. Kosmahl M, Wagner J, Peters K, et al.: Serous cystic neoplasms of the pancreas: An immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. Am J Surg Pathol 2004; 28: 339-346.
56. Holen KD, Klimstra DS, Hummer A, et al.: Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol 2002; 20: 4673-4678.
57. Hoorens A, Lemoine NR, McLellan E, et al.: Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 1993; 143: 685-698.
58. Hoorens A, Gebhard F, Kraft K, et al.: Pancreatoblastoma in an adult: Its separation from acinar cell carcinoma. Virchows Arch 1994; 424: 485-490.
59. Klimstra DS, Hruban R, Kloppel G, Morohoshi T, et al.: Acinar cell neoplasms of the pancreas. In:, Bosman F, Carneiro F, Hruban RH, Theise ND, editors. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010. pp. 314-318.
60. Klimstra DS, Heffess CS, Oertel JE, et al.: Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol 1992; 16: 815-837.
61. Basturk O, Zamboni G, Klimstra DS, et al.: Intraductal and papillary variants of acinar cell carcinomas: A new addition to the challenging differential diagnosis of intraductal neoplasms. Am J Surg Pathol 2007; 31: 363-370.
62. Ban D, Shimada K, Sekine S, et al.: Pancreatic ducts as an important route of tumor extension for acinar cell carcinoma of the pancreas. Am J Surg Pathol 2010; 34: 1025-1036.
63. Shorter NA, Glick RD, Klimstra DS, et al.: Malignant pancreatic tumors in childhood and adolescence: The Memorial Sloan-Kettering experience, 1967 to present. J Pediatr Surg 2002; 37: 887-892.
64. Benjamin E, Wright DH,: Adenocarcinoma of the pancreas of childhood: A report of two cases. Histopathology 1980; 4: 87-104.
65. Dhebri AR, Connor S, Campbell F, et al.: Diagnosis, treatment and outcome of pancreatoblastoma. Pancreatology 2004; 4: 441-451, discussion 452-443.
66. Klimstra D, Arnold R, Capella C, et al.: Neuroendocrine neoplasms of the pancreas. In:, Bosman F, Carneiro F, Hruban R, Theise N, editors. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010. pp. 322-326.
67. Kent RB III, van Heerden JA, Weiland LH,: Nonfunctioning islet cell tumors. Ann Surg 1981; 193: 185-190.
68. Kimura W, Kuroda A, Morioka Y,: Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 1991; 36: 933-942.
69. Klimstra DS, Modlin IR, Coppola D, et al.: The pathologic classification of neuroendocrine tumors: A review of nomenclature, grading, and staging systems. Pancreas 2010; 39: 707-712.
70. Hammond EH, Yowell RL, Flinner RL,: Neuroendocrine carcinomas: Role of immunocytochemistry and electron microscopy. Hum Pathol 1998; 29: 1367-1371.
71. Lubensky IA, Pack S, Ault D, et al.: Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: Histopathological and molecular genetic analysis. Am J Pathol 1998; 153: 223-231.
72. Jiao Y, Shi C, Edil BH, et al.: DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011; 331: 1199-1203.
73. Yachida S, Vakiani E, White CM, et al.: Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 2012; 36: 173-184.
74. Hochwald SN, Zee S, Conlon KC, et al.: Prognostic factors in pancreatic endocrine neoplasms: An analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002; 20: 2633-2642.
75. Deshpande V, Fernandez-del Castillo C, Muzikansky A, et al.: Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 2004; 28: 1145-1153.
76. Tanaka Y, Kato K, Notohara K, et al.: Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 2001; 61: 8401-8404.
77. Muller-Hocker J, Zietz CH, Sendelhofert A,: Deregulated expression of cell cycle-associated proteins in solid pseudopapillary tumor of the pancreas. Mod Pathol 2001; 14: 47-53.
78. Adsay NV, Andea A, Basturk O, et al.: Secondary tumors of the pancreas: An analysis of a surgical and autopsy database and review of the literature. Virchows Arch 2004; 444: 527-535.
79. Ferrozzi F, Bova D, Campodonico F, et al.: Pancreatic metastases: CT assessment. Eur Radiol 1997; 7: 241-245.